NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹21 Cr | ₹15 Cr | ₹21 Cr | ₹14 Cr | ₹6.50 Cr |
What is the latest Short Term Loans and Advances ratio of NGL FINECHEM ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹21 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹6.50 Cr |
How is Short Term Loans and Advances of NGL FINECHEM Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹21 Cr | 40.13 | |
Mar2023 | ₹15 Cr | -28.97 | |
Mar2022 | ₹21 Cr | 51.58 | |
Mar2021 | ₹14 Cr | 114.79 | |
Mar2020 | ₹6.50 Cr | - |
Compare Short Term Loans and Advances of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹654.0 Cr | -2.7% | -12% | -52.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -2.7% |
-12% |
-52.5% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses